OpenURL Connection Search

Select item for more details and to access through your institution.

Convalescent human IgG, but not IgM, from COVID-19 survivors confers dosedependent protection against SARS-CoV-2 replication and disease in hamsters.
Published in:
Frontiers in Immunology, 2023, v. 14, p. 1, doi. 10.3389/fimmu.2023.1138629
By:
- King, Hannah A. D.;
- Dussupt, Vincent;
- Mendez-Rivera, Letzibeth;
- Slike, Bonnie M.;
- Tran, Ursula;
- Jackson, Nathan D.;
- Barkei, Erica;
- Zemil, Michelle;
- Tourtellott-Fogt, Emily;
- Kuklis, Caitlin H.;
- Soman, Sandrine;
- Ahmed, Aslaa;
- Porto, Maciel;
- Kitajewski, Christopher;
- Spence, Brittany;
- Benetiene, Dalia;
- Wieczorek, Lindsay;
- Kar, Swagata;
- Gromowski, Gregory;
- Polonis, Victoria R.
Publication type:
Article
Differences in neutralizing antibody sensitivities and envelope characteristics indicate distinct antigenic properties of Nigerian HIV-1 subtype G and CRF02_AG.
Published in:
Virology Journal, 2024, v. 21, n. 1, p. 1, doi. 10.1186/s12985-024-02394-y
By:
- Wieczorek, Lindsay;
- Chang, David;
- Sanders-Buell, Eric;
- Zemil, Michelle;
- Martinez, Elizabeth;
- Schoen, Jesse;
- Chenine, Agnes-Laurence;
- Molnar, Sebastian;
- Barrows, Brittani;
- Poltavee, Kultida;
- Charurat, Man E.;
- Abimiku, Alash'le;
- Blattner, William;
- Iroezindu, Michael;
- Kokogho, Afoke;
- Michael, Nelson L.;
- Crowell, Trevor A.;
- Ake, Julie A.;
- Tovanabutra, Sodsai;
- Polonis, Victoria R.
Publication type:
Article
Evaluation of Antibody-Dependent Fc-Mediated Viral Entry, as Compared With Neutralization, in SARS-CoV-2 Infection.
Published in:
Frontiers in Immunology, 2022, v. 13, p. 1, doi. 10.3389/fimmu.2022.901217
By:
- Wieczorek, Lindsay;
- Zemil, Michelle;
- Merbah, Mélanie;
- Dussupt, Vincent;
- Kavusak, Erin;
- Molnar, Sebastian;
- Heller, Jonah;
- Beckman, Bradley;
- Wollen-Roberts, Suzanne;
- Peachman, Kristina K.;
- Darden, Janice M.;
- Krebs, Shelly;
- Rolland, Morgane;
- Peel, Sheila A.;
- Polonis, Victoria R.
Publication type:
Article
Evolution of HIV-1 envelope towards reduced neutralization sensitivity, as demonstrated by contemporary HIV-1 subtype B from the United States.
Published in:
PLoS Pathogens, 2023, v. 19, n. 12, p. 1, doi. 10.1371/journal.ppat.1011780
By:
- Wieczorek, Lindsay;
- Sanders-Buell, Eric;
- Zemil, Michelle;
- Lewitus, Eric;
- Kavusak, Erin;
- Heller, Jonah;
- Molnar, Sebastian;
- Rao, Mekhala;
- Smith, Gabriel;
- Bose, Meera;
- Nguyen, Amy;
- Dhungana, Adwitiya;
- Okada, Katherine;
- Parisi, Kelly;
- Silas, Daniel;
- Slike, Bonnie;
- Ganesan, Anuradha;
- Okulicz, Jason;
- Lalani, Tahaniyat;
- Agan, Brian K.
Publication type:
Article
A SARS-CoV-2 spike ferritin nanoparticle vaccine protects hamsters against Alpha and Beta virus variant challenge.
Published in:
NPJ Vaccines, 2021, v. 6, n. 1, p. 1, doi. 10.1038/s41541-021-00392-7
By:
- Wuertz, Kathryn McGuckin;
- Barkei, Erica K.;
- Chen, Wei-Hung;
- Martinez, Elizabeth J.;
- Lakhal-Naouar, Ines;
- Jagodzinski, Linda L.;
- Paquin-Proulx, Dominic;
- Gromowski, Gregory D.;
- Swafford, Isabella;
- Ganesh, Akshaya;
- Dong, Ming;
- Zeng, Xiankun;
- Thomas, Paul V.;
- Sankhala, Rajeshwer S.;
- Hajduczki, Agnes;
- Peterson, Caroline E.;
- Kuklis, Caitlin;
- Soman, Sandrine;
- Wieczorek, Lindsay;
- Zemil, Michelle
Publication type:
Article
Diverse array of neutralizing antibodies elicited upon Spike Ferritin Nanoparticle vaccination in rhesus macaques.
Published in:
Nature Communications, 2024, v. 15, n. 1, p. 1, doi. 10.1038/s41467-023-44265-0
By:
- Sankhala, Rajeshwer S.;
- Lal, Kerri G.;
- Jensen, Jaime L.;
- Dussupt, Vincent;
- Mendez-Rivera, Letzibeth;
- Bai, Hongjun;
- Wieczorek, Lindsay;
- Mayer, Sandra V.;
- Zemil, Michelle;
- Wagner, Danielle A.;
- Townsley, Samantha M.;
- Hajduczki, Agnes;
- Chang, William C.;
- Chen, Wei-Hung;
- Donofrio, Gina C.;
- Jian, Ningbo;
- King, Hannah A. D.;
- Lorang, Cynthia G.;
- Martinez, Elizabeth J.;
- Rees, Phyllis A.
Publication type:
Article
Contemporary HIV-1 consensus Env with AI-assisted redesigned hypervariable loops promote antibody binding.
Published in:
Nature Communications, 2024, v. 15, n. 1, p. 1, doi. 10.1038/s41467-024-48139-x
By:
- Bai, Hongjun;
- Lewitus, Eric;
- Li, Yifan;
- Thomas, Paul V.;
- Zemil, Michelle;
- Merbah, Mélanie;
- Peterson, Caroline E.;
- Thuraisamy, Thujitha;
- Rees, Phyllis A.;
- Hajduczki, Agnes;
- Dussupt, Vincent;
- Slike, Bonnie;
- Mendez-Rivera, Letzibeth;
- Schmid, Annika;
- Kavusak, Erin;
- Rao, Mekhala;
- Smith, Gabriel;
- Frey, Jessica;
- Sims, Alicea;
- Wieczorek, Lindsay
Publication type:
Article

Found: 7

Convalescent human IgG, but not IgM, from COVID-19 survivors confers dosedependent protection against SARS-CoV-2 replication and disease in hamsters.

Differences in neutralizing antibody sensitivities and envelope characteristics indicate distinct antigenic properties of Nigerian HIV-1 subtype G and CRF02_AG.

Evaluation of Antibody-Dependent Fc-Mediated Viral Entry, as Compared With Neutralization, in SARS-CoV-2 Infection.

Evolution of HIV-1 envelope towards reduced neutralization sensitivity, as demonstrated by contemporary HIV-1 subtype B from the United States.

A SARS-CoV-2 spike ferritin nanoparticle vaccine protects hamsters against Alpha and Beta virus variant challenge.

Diverse array of neutralizing antibodies elicited upon Spike Ferritin Nanoparticle vaccination in rhesus macaques.

Contemporary HIV-1 consensus Env with AI-assisted redesigned hypervariable loops promote antibody binding.